Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MicroRNAs as Biomarkers in Hypertrophic Cardiomyopathy: Current State of the Art

6 Apr 2021

Abstract excerpt

BACKGROUND: Hypertrophic Cardiomyopathy (HCM) is the most common inherited Cardiomyopathy. The hallmark of HCM is myocardial fibrosis that contributes to heart failure, arrhythmias and sudden cardiac death. OBJECTIVE: Currently, there are no reliable serum biomarkers for the detection of myocardial fibrosis, while cardiac magnetic resonance (CMR) is an imaging technique to detect myocardial fibrosis. MicroRNAs...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiac Fibrosis and Remodeling
Share to Cardiomyopathy and Myosin Studies
Share to Cardiovascular Function and Risk Factors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33820510
DOI: 10.2174/0929867328666210405122703

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MicroRNAs as Biomarkers in Hypertrophic Cardiomyopathy: Current State of the ArtPMID 33820510Read ↗

MicroRNAs in hypertrophic cardiomyopathy: pathogenesis, diagnosis, treatment potential and roles as clinical biomarkersSemantic proximity Read ↗

Circulating MicroRNAs Identify Early Phenotypic Changes in Sarcomeric Hypertrophic Cardiomyopathy.Semantic proximity Read ↗

MicroRNAs in Hypertrophic, Arrhythmogenic and Dilated CardiomyopathySemantic proximity Read ↗

A Novel miRNA Screen Identifies miRNA-4454 as a Candidate Biomarker for Ventricular Fibrosis in Patients with Hypertrophic CardiomyopathySemantic proximity Read ↗

Blood-based microRNA signatures differentiate various forms of cardiac hypertrophy.Semantic proximity Read ↗

A critical approach for successful use of circulating microRNAs as biomarkers in cardiovascular diseases: the case of hypertrophic cardiomyopathySemantic proximity Read ↗

MiR-1-3p that correlates with left ventricular function of HCM can serve as a potential target and differentiate HCM from DCMSemantic proximity Read ↗

Circulating miR-29a, Among Other Up-Regulated MicroRNAs, Is the Only Biomarker for Both Hypertrophy and Fibrosis in Patients With Hypertrophic CardiomyopathySemantic proximity Read ↗

Global MicroRNA Profiling of the Mouse Ventricles during Development of Severe Hypertrophic Cardiomyopathy and Heart FailureSemantic proximity Read ↗

New Insights into the Functions of MicroRNAs in Cardiac Fibrosis: From Mechanisms to Therapeutic StrategiesSemantic proximity Read ↗

Characterisation of circulating microRNA-21 levels in patients with hypertrophic cardiomyopathySemantic proximity Read ↗

The Role of MicroRNAs in Dilated Cardiomyopathy: New Insights for an Old EntitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.